Search results

Tools and resources to help you implement guidance and quality standards at work.

Tools and resources to help you implement guidance and quality standards at work.

NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography .

Result type

Medtech innovation briefing

Published

5 January 2021

This indicator covers the establishing and maintaining of a register of patients aged 18 or over with a BMI of 27.5 kg/m2 or more (or 30 kg/m2 or more if ethnicity is recorded as White) in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM222

Result type

General practice indicators suitable for use in QOF

Published

7 September 2022

This indicator covers the establishing and maintaining of a register of patients aged 18 or over with a BMI of 23 kg/m2 or more (or 25 kg/m2 or more if ethnicity is recorded as White) in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM221

Result type

General practice indicators suitable for use in QOF

Published

7 September 2022

Get expert advice and support from NICE International, part of the UK’s National Institute for Health and Care Excellence, for a project in your country

This indicator covers the percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM173

Result type

General practice indicators suitable for use in QOF

Last updated

30 April 2020

Good practice guidance – Interim process statement

Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the

Result type

Diagnostics guidance

Published

17 June 2020

NICE has developed a medtech innovation briefing (MIB) on HemaClear for bloodless surgical field during limb surgery .

Result type

Medtech innovation briefing

Published

15 July 2019

Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Result type

Evidence summary

Published

21 March 2017

Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia in adults.

Result type

Technology appraisal guidance

Published

7 August 2024

Evidence-based recommendations on superficial venous arterialisation for chronic limb threatening ischaemia in adults. This involves joining an artery in the lower leg to a large vein to divert blood flow through the vein towards the foot, bypassing the blocked arteries.

Result type

Interventional procedures guidance

Published

24 August 2022

Evidence-based recommendations on percutaneous deep venous arterialisation for chronic limb-threatening ischaemia. This involves making a hole between a blocked artery and a vein, allowing the blood to flow into the leg beyond the blockage.

Result type

Interventional procedures guidance

Published

18 October 2023

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults.

Result type

Technology appraisal guidance

Published

29 August 2018

Evidence-based recommendations on pegunigalsidase alfa (Elfabrio) for Fabry disease (also known as alpha-galactosidase deficiency) in adults.

Result type

Technology appraisal guidance

Published

4 October 2023

Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in adults who have had previous endocrine therapy.

Result type

Technology appraisal guidance

Published

31 March 2021

Evidence-based recommendations on coronary sinus narrowing device implantation for refractory angina in adults. This involves putting a device into the coronary sinus to narrow it with the aim of improving the flow of oxygenated blood throughout the heart muscle.

Result type

Interventional procedures guidance

Published

24 November 2021

Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet in adults.

Result type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on ravulizumab (Ultomiris) for treating atypical haemolytic uraemic syndrome in people weighing 10 kg or more.

Result type

Technology appraisal guidance

Published

23 June 2021

This indicator covers the percentage of patients with diabetes on the register, aged 79 years and under without moderate or severe frailty, in whom the last blood pressure reading (measured in the preceding 12 months) is less than 135/85 mmHg if using ambulatory or home monitoring, or less than 140/90 mmHg if measured in clinic. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM233

Result type

General practice indicators suitable for use in QOF

Published

19 August 2023

Evidence-based recommendations on short-pulse transscleral cyclophotocoagulation for glaucoma. This involves using repeated short pulses of laser energy to destroy some of the cells in the eye that produce fluid.

Result type

Interventional procedures guidance

Published

28 April 2021

Evidence-based recommendations on transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine in adults. This involves attaching a small device on the forehead to send small electrical currents to the nerves that bring sensation to the upper eyelids, forehead and scalp.

Result type

Interventional procedures guidance

Published

26 October 2022

Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.

Result type

Technology appraisal guidance

Published

18 April 2018

NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .

Result type

Medtech innovation briefing

Published

29 November 2016

Evidence-based recommendations on ruxolitinib (Jakavi) for polycythaemia vera in adults.

Result type

Technology appraisal guidance

Published

18 October 2023

Summary of the evidence on eculizumab for treating C3 glomerulopathy in the native kidney inform local NHS planning and decision-making

Result type

Evidence summary

Published

22 December 2015

Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.

Result type

Medical technologies guidance

Last updated

25 March 2019

2018 we published the NICEimpact report on maternity. This considered how NICE's evidence-based guidance might contribute to...

Tailored content for our communities: Medicines and prescribing, general practice, social care, the public, library and knowledge services and local government.

Medical technologies evaluation programme methods guide

NICE has developed a medtech innovation briefing (MIB) on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume

Result type

Medtech innovation briefing

Published

22 January 2016

Evidence-based recommendations on microwave ablation for primary or metastatic cancer in the lung in adults. This involves inserting a probe into the lung, through the skin of the chest, to send microwaves into the cancer cells. This produces heat, aiming to destroy the cancer (ablation).

Result type

Interventional procedures guidance

Published

2 February 2022

Evidence summaries: unlicensed and off-label medicines – Interim process statement

Evidence-based recommendations on deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults. This involves implanting an electrode in the brain and an electrical stimulator under the skin on the chest.

Result type

Interventional procedures guidance

Published

28 April 2021

Help us improve NICE: take part in research to help us develop better products and services.

Evidence-based recommendations on erenumab (Aimovig) for preventing migraine in adults.

Result type

Technology appraisal guidance

Published

10 March 2021

Evidence-based recommendations on pembrolizumab (Keytruda) for treating relapsed or refractory classical Hodgkin lymphoma in adults.

Result type

Technology appraisal guidance

Last updated

1 May 2024

Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism. This involves using ultrasound waves and a drug to break up the clot.

Result type

Interventional procedures guidance

Published

26 June 2015

Evidence-based recommendations on tixagevimab plus cilgavimab (Evusheld) for preventing COVID-19 in adults.

Result type

Technology appraisal guidance

Published

14 June 2023

NICE has developed a medtech innovation briefing (MIB) on plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer .

Result type

Medtech innovation briefing

Published

18 January 2018

Evidence-based recommendations on transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain in adults. This involves delivering focused ultrasound to a small part of the brain (in the thalamus) responsible for transmitting pain signals to destroy it.

Result type

Interventional procedures guidance

Published

28 November 2018

Evidence-based recommendations on galcanezumab (Emgality) for preventing migraine in adults.

Result type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are

Result type

Diagnostics guidance

Published

13 November 2019

Evidence-based recommendations on avatrombopag (Doptelet) for treating severe thrombocytopenia in adults with chronic liver disease needing a planned invasive procedure.

Result type

Technology appraisal guidance

Published

24 June 2020

Evidence-based recommendations on extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women. This involves putting 2 small balloons on either side of the tube that carries urine from the bladder to support it and reduce leaks.

Result type

Interventional procedures guidance

Published

22 March 2017

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves positioning a temporary implant in the urethra to increase the flow of urine.

Result type

Interventional procedures guidance

Published

21 September 2022

NICE has developed a medtech innovation briefing (MIB) on the CareLink network service for remote monitoring of people with cardiac devices

Result type

Medtech innovation briefing

Published

24 May 2016

Healthy start vitamins: special report on cost effectiveness

Medical technologies evaluation programme process guide